BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26187095)

  • 21. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoactivation of human blood coagulation factor XII on dextran derivatives of different molecular weight.
    Tazi S; Tans G; Hemker HC; Nigretto JM
    Thromb Res; 1992 Sep; 67(6):665-76. PubMed ID: 1279836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procoagulant activity of surface-immobilized Hageman factor.
    Chatterjee K; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Nov; 27(33):5643-50. PubMed ID: 16905185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on contact activation: effects of surface and inhibitors.
    Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
    Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies.
    Bernardo MM; Day DE; Halvorson HR; Olson ST; Shore JD
    J Biol Chem; 1993 Jun; 268(17):12477-83. PubMed ID: 8509387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the contact pathway in thrombus propagation.
    Gruber A
    Thromb Res; 2014 May; 133 Suppl 1():S45-7. PubMed ID: 24759142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII.
    Samuel M; Samuel E; Villanueva GB
    Biochem Biophys Res Commun; 1993 Feb; 191(1):110-7. PubMed ID: 8447816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An HMG-I protein from human endothelial cells apparently is secreted and impairs activation of Hageman factor (factor XII).
    Donaldson VH; Wagner CJ; Mitchell BH; Mandle R
    Proc Assoc Am Physicians; 1998; 110(2):140-9. PubMed ID: 9542770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.
    Nickel KF; Ronquist G; Langer F; Labberton L; Fuchs TA; Bokemeyer C; Sauter G; Graefen M; Mackman N; Stavrou EX; Ronquist G; Renné T
    Blood; 2015 Sep; 126(11):1379-89. PubMed ID: 26153520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of coronary heart disease and activation of factor XII in middle-aged men.
    Miller GJ; Esnouf MP; Burgess AI; Cooper JA; Mitchell JP
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2103-6. PubMed ID: 9351378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The surface-dependent autoactivation mechanism of factor XII.
    Røjkjaer R; Schousboe I
    Eur J Biochem; 1997 Jan; 243(1-2):160-6. PubMed ID: 9030735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies.
    Samuel M; Pixley RA; Villanueva MA; Colman RW; Villanueva GB
    J Biol Chem; 1992 Sep; 267(27):19691-7. PubMed ID: 1527088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation.
    Schousboe I; Rasmussen MS
    Int J Biochem; 1988; 20(8):787-92. PubMed ID: 3169363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The low pH stability of human coagulation factor XII (Hageman factor) is due to reversible conformational transitions.
    Samuel M; Samuel E; Villanueva GB
    Thromb Res; 1994 Aug; 75(3):259-68. PubMed ID: 7992237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of the contact system of human plasma by polysaccharide sulfates.
    Silverberg M; Diehl SV
    Ann N Y Acad Sci; 1987; 516():268-79. PubMed ID: 2449841
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface.
    Mitropoulos KA; Martin JC; Stirling Y; Morrisey JH; Cooper JA
    Thromb Res; 1995 Apr; 78(1):67-75. PubMed ID: 7778067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.